JPMORGAN CHASE & CO - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,068,387
-54.3%
2,815,034
-4.0%
0.00%
-100.0%
Q2 2023$6,712,377
-16.5%
2,931,169
-11.3%
0.00%0.0%
Q1 2023$8,034,000
+128279.7%
3,305,991
+0.9%
0.00%0.0%
Q4 2022$6,258
-99.9%
3,276,798
+1.6%
0.00%0.0%
Q3 2022$7,743,000
+267.5%
3,226,433
+184.8%
0.00%
Q2 2022$2,107,000
-10.7%
1,132,777
+0.3%
0.00%
Q1 2022$2,360,000
-47.8%
1,129,321
-1.6%
0.00%
-100.0%
Q4 2021$4,524,000
-18.8%
1,148,090
-0.8%
0.00%0.0%
Q3 2021$5,568,000
-7.6%
1,157,703
-11.8%
0.00%0.0%
Q2 2021$6,027,000
+160.7%
1,313,161
+233.4%
0.00%
Q1 2021$2,312,000
+51.5%
393,886
-11.7%
0.00%
Q4 2020$1,526,000
+1595.6%
446,111
+623.1%
0.00%
Q3 2020$90,000
+119.5%
61,694
+205.6%
0.00%
Q2 2020$41,000
+5.1%
20,191
+0.5%
0.00%
Q1 2020$39,000
-55.2%
20,086
-5.0%
0.00%
Q4 2019$87,000
+50.0%
21,153
+9.2%
0.00%
Q3 2019$58,000
-49.1%
19,371
+4.4%
0.00%
Q2 2019$114,000
+29.5%
18,550
+17.8%
0.00%
Q1 2019$88,000
-15.4%
15,742
+0.6%
0.00%
Q4 2018$104,000
-31.1%
15,652
+10.9%
0.00%
Q3 2018$151,000
-77.9%
14,116
-75.2%
0.00%
Q2 2018$684,000
-20.4%
56,985
-43.2%
0.00%
Q1 2018$859,000
-20.1%
100,309
-7.8%
0.00%
Q4 2017$1,075,000
-16.4%
108,826
+4.6%
0.00%
Q3 2017$1,286,000
-27.7%
104,041
-3.7%
0.00%
Q2 2017$1,778,000
-55.3%
108,093
-61.1%
0.00%
-100.0%
Q1 2017$3,980,000
-5.4%
277,556
-8.8%
0.00%0.0%
Q4 2016$4,207,000
-20.0%
304,210
+4.6%
0.00%0.0%
Q3 2016$5,256,000
+193.8%
290,850
+133.3%
0.00%
Q2 2016$1,789,000
+14.3%
124,693
-4.8%
0.00%
Q1 2016$1,565,000
-12.7%
130,993
-2.7%
0.00%
Q4 2015$1,793,000
+21.2%
134,693
-2.2%
0.00%
Q3 2015$1,479,000137,6930.00%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$37,033,000100.00%
Artal Group S.A. 58,274,650$499,413,0006.25%
SECTOR GAMMA AS 854,592$7,324,0001.32%
NEA Management Company, LLC 2,382,286$20,416,0000.91%
Virtus ETF Advisers LLC 89,845$770,0000.67%
Malaga Cove Capital, LLC 59,701$512,0000.28%
MARSHALL WACE, LLP 736,545$6,312,0000.26%
USS Investment Management Ltd 2,741,942$22,607,0000.25%
CLEARBRIDGE, LLC 1,172,117$10,045,0000.22%
WEDBUSH SECURITIES INC 155,396$1,332,0000.17%
View complete list of LEXICON PHARMACEUTICALS INC shareholders